Drug Pipeline News

Latest News

FDA grants IND clearance to DARE-VVA1 for dyspareunia | Image Credit: © Postmodern Studio - © Postmodern Studio - stock.adobe.com.
FDA grants IND clearance to DARE-VVA1 for dyspareunia

December 7th 2023

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive  | Image Credit: © JPC-PROD - © JPC-PROD - stock.adobe.com.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive

December 5th 2023

Phase 2b study indicates Sildenafil Cream effective against female sexual arousal disorder | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
Phase 2b study indicates Sildenafil Cream effective against female sexual arousal disorder

November 2nd 2023

Ibrexafungerp tablets receive nationwide recall | Image Credit: © Veranika - © Veranika - stock.adobe.com.
Ibrexafungerp tablets receive nationwide recall

September 28th 2023

CDC recommends Pfizer’s maternal RSV vaccine to protect newborns | Image Credit: © JHVEPhoto - © JHVEPhoto - stock.adobe.com.
CDC recommends Pfizer’s maternal RSV vaccine to protect newborns

September 26th 2023

Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.